Based on a composite score of 4.45/10, we rate GSK as a Netural. Our analysis breaks down into 3.88/10 for Fundamentals, 4.69/10 for Technicals, and 4.61/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of GSK?
GSK presents a Netural setup with a Technical Score of 4.69/10. Key technical indicators highlight an RSI of 83.89 and a MACD of 2.16, with the trend anchored by the 50-Day SMA at 49.83. Traders should monitor key support at 58.06 and resistance at 59.95.
Is GSK undervalued or overvalued?
GSK scores 3.88/10 on fundamentals and holds a Fair valuation at present. Backed by its 39.36% ROE, 19.25% net margin, 15.97 P/E ratio, 5.72 P/B ratio, and 139.77% earnings growth, these metrics solidify its Netural investment rating.
Is money flowing into or out of GSK?
GSK holds a Bearish analyst rating, with 100% of experts assigning a Sell grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.61/10 (Netural).
Is GSK a Good Buy Right Now?
Based on a composite score of 4.45/10, we rate GSK as a Netural. Our analysis breaks down into 3.88/10 for Fundamentals, 4.69/10 for Technicals, and 4.61/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is GSK undervalued or overvalued?
GSK scores 3.88/10 on fundamentals and holds a Fair valuation at present. Backed by its 39.36% ROE, 19.25% net margin, 15.97 P/E ratio, 5.72 P/B ratio, and 139.77% earnings growth, these metrics solidify its Netural investment rating.
Technical Analysis of GSK?
GSK presents a Netural setup with a Technical Score of 4.69/10. Key technical indicators highlight an RSI of 83.89 and a MACD of 2.16, with the trend anchored by the 50-Day SMA at 49.83. Traders should monitor key support at 58.06 and resistance at 59.95.
Is money flowing into or out of GSK?
GSK holds a Bearish analyst rating, with 100% of experts assigning a Sell grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.61/10 (Netural).
